Bailout Percutaneous Intervention for Acute Aortic Occlusion.

Aymen Najjar, Mejdi Ben Messaoud, Mezri Maatouk, Mohamed Amin Mesrati, Habib Gamra, Nidhal Bouchahda

Abstract readCase Reports

In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aymen NajjarCardiology "A" Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Laboratory, University of Monastir, Monastir, Tunisia. Electronic address: najjar_aymanus@yahoo.fr.

Mejdi Ben MessaoudCardiology "A" Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Laboratory, University of Monastir, Monastir, Tunisia.

Mezri MaatoukRadiology "A" Department, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.

Mohamed Amin MesratiLegal Medicine Department, Taher Sfar University Hospital, Mahdia, Tunisia.

Habib GamraCardiology "A" Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Laboratory, University of Monastir, Monastir, Tunisia.

Nidhal BouchahdaCardiology "A" Department, Fattouma Bourguiba University Hospital, Cardiothrombosis Laboratory, University of Monastir, Monastir, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute aortic occlusion is a rare but life-threatening condition. Prompt diagnosis and urgent revascularization are keys to patient survival. CASE SUMMARY: A 63-year-old man was admitted with acute embolic aortic occlusion. Appropriate means for urgent revascularization were not readily available. Primary percutaneous angioplasty of the aorta with catheter-directed thrombolysis and balloon angioplasty using coronary artery-dedicated devices were successfully performed. DISCUSSION: Acute aortic occlusion is commonly caused by in situ thrombosis or saddle emboli. Surgical management such as aortobifemoral bypass and aortic endarterectomy have been considered the standard approach treatments. However, endovascular and percutaneous revascularization techniques have become more commonly used over time. In our salvage procedure, we used coronary artery-specific devices with catheter-directed thrombolysis. To the best of our knowledge, this "off-label" technique has not been previously reported. TAKE-HOME MESSAGE: Coronary artery-dedicated devices might be safely used as a bailout percutaneous revascularization intervention in acute aortic occlusion.

Indexed as

aortaperipheral vascular diseasethrombus

Identifiers

PMID40816832

DOI10.1016/j.jaccas.2025.104643

PMCPMC12462114

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.